Clinical Trials Directory

Trials / Completed

CompletedNCT03728686

Response to Endotracheal Tube Intubation at Different Time of Fentanyl Given During Induction

The Hemodynamic Response to Endotracheal Intubation at Different Time of Fentanyl Given During Induction: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Chien-Chung,Huang · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

Opioids have been used to modify the hemodynamic response associated with laryngoscopy and tracheal intubation. To seek the correlation of Fentanyl given time, we will analysis the data collected from vital signs monitoring machine. Patients'details will be recorded too.

Detailed description

Laryngoscopy and intubation often provoke hypertension and tachycardia due to the stimulation both sympathetic and sympathoadrenal activities. While the adverse hemodynamic effects of laryngoscopy and endotracheal intubation can precipitate myocardial ischemia, even in patients without hypertension, the responses are exaggerated in patients with hypertension . In the previous studies , many drugs, including opioids and beta-blockers, have been used to modify the hemodynamic response associated with laryngoscopy and tracheal intubation. To seek the correlation of Fentanyl given time, we will analysis the data collected from vital signs monitoring machine. All patients were premedicated with Midazolam 0.1mg/kg , Lidocaine 0.5mg/kg (L), Propofol 2mg/kg (P), Rocuronium 1mg/kg (R) before induction of general anesthesia. Laryngoscopy lasting a maximum of 30 s was attempted 3 min after administration of the induction agents. Fentanyl 2mcg/kg was given at different time before intubation.

Conditions

Interventions

TypeNameDescription
OTHERDifferent given timeFentanyl 2mcg/kg (F) was given at either 1,2,3 minutes before intubation

Timeline

Start date
2016-12-16
Primary completion
2018-07-30
Completion
2018-07-30
First posted
2018-11-02
Last updated
2018-11-06

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03728686. Inclusion in this directory is not an endorsement.